Complement Factor B Variant Protects Against Age-Related Macular Degeneration
Author Information
Author(s): Hughes Anne E., Mullan Gemma M., Bradley Declan T.
Primary Institution: Centre for Public Health, Queen’s University Belfast, UK
Hypothesis
Is the 32W variant of complement factor B associated with decreased risk of age-related macular degeneration (AMD)?
Conclusion
The 32W variant of complement factor B is associated with protection against AMD.
Supporting Evidence
- The 32W variant was associated with an odds ratio of 0.64 for protection against neovascular AMD.
- Meta-analysis showed a combined odds ratio of 0.75 for 32W compared to 32R.
- The protective effect of 32W is less strong than that associated with the 32Q variant.
Takeaway
This study found that a specific gene variant can help protect people from a serious eye disease that can cause blindness.
Methodology
Genotyping of 367 cases with neovascular AMD and 251 disease-free controls, followed by logistic regression and meta-analysis.
Limitations
The study may not account for all genetic and environmental factors influencing AMD risk.
Participant Demographics
Participants were primarily of European ancestry, with a median age of 76 for AMD cases and 75 for controls.
Statistical Information
P-Value
p<0.05
Confidence Interval
0.42–0.98
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website